hotspot -WSS

hotspot

author：explore 2025-09-03 14:37:36 - browse：11563

Scientist pipetting in a biotech lab -- biotech coverage from STAT — A researcher working in the lab at Crinetics Pharmaceuticals in San Diego. Courtesy Crinetics

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego biotech a step closer to applying for Food and Drug Administration approval — and entry into a crowded market with blockbuster therapies sold by pharma giants.

In the Phase 3 study, dubbed PATHFNDR-1, nearly 60 patients were randomly assigned to receive a placebo or a daily dose of paltusotine, an oral medicine designed to lower levels of growth hormone, which is produced in excess by people with acromegaly. After 36 weeks of treatment, 25 of the 30 patients given the drug had growth-factor levels that were within the normal range compared to just 1 of 28 participants who took the placebo, a difference that was statistically significant. Researchers also found that the treatment’s side effects were mild overall.

Crinetics plans to file for FDA approval if it gets positive results from a second, ongoing Phase 3 trial of the drug in acromegaly patients. The biotech expects results from that study, known as PATHFNDR-2, by the first quarter of next year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Why the advice to take all your antibiotics may be wrong

WSS

Take antibiotics after sex, CDC recommends for certain risk groups

New chief aims to remake Sanofi Genzyme

An outdated Medicare rule harms dementia patients with anxiety

CMS got Medicare Advantage quality rating wrong, judge rules

Why Marc Tessier

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

focus

hotspot

hotspot

Hollywood unions extend contract negotiations for actors

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Hollywood unions extend contract negotiations for actors

Elevance PBM president out as customers face prescription chaos

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New chief aims to remake Sanofi Genzyme

Heart attack and stroke risk calculators need revising

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

The cancer drug shortage isn’t new — and neither are the solutions

Why the advice to take all your antibiotics may be wrong

hotspot

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

BD to buy Edwards patient monitoring unit for $4.2 billion

Fight over Supreme Court dialysis ruling puts kidney patients at risk

A former Republican legislative candidate has been charged for his role in the US Capitol riot

CMS got Medicare Advantage quality rating wrong, judge rules

Why the advice to take all your antibiotics may be wrong

leisure time

hotspot

explore

hotspot